David Chang

Feasibility of biology-guided radiotherapy using PSMA-PET to boost to dominant intraprostatic tumour

Mathieu Gaudreault, David Chang, Nicholas Hardcastle, Price Jackson, Tomas Kron, Michael S Hofman, Shankar Siva

Journal article  |  2022  |  CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY

BACKGROUND: Biology-guided radiotherapy (BgRT) delivers dose to tumours triggered from positron emission tomography (PET) detectio..

Utility of Biology-Guided Radiotherapy to De Novo Metastases Diagnosed During Staging of High-Risk Biopsy-Proven Prostate Cancer

Mathieu Gaudreault, David Chang, Nicholas Hardcastle, Price Jackson, Tomas Kron, Gerard G Hanna, Michael S Hofman, Shankar Siva

Journal article  |  2022  |  FRONTIERS IN ONCOLOGY

BACKGROUND: Biology-guided radiotherapy (BgRT) uses real-time functional imaging to guide radiation therapy treatment. Positron em..

Why quality assurance is necessary in gynecologic radiation oncology

David Chang, Alisha Moore, Sylvia van Dyk, Pearly Khaw

Journal article  |  2022  |  INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Quality assurance (QA) in radiation oncology involves all checks and processes that ensure that radiotherapy is delivered in an op..

Evaluation of PSMA-PET Biology-Guided Radiotherapy Sequential Boost to the PSMA-avid Subvolume in the Prostate Region in Low-Volume Advanced Prostate Cancer

M Gaudreault, D Chang, N Hardcastle, P Jackson, T Kron, MS Hofman, GG Hanna, SM Shirvani, S Siva

Conference Proceedings  |  2021  |  INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

PURPOSE/OBJECTIVE(S): Biology-guided radiation therapy (BgRT) is a new technology that aims to deliver radiation based on detectin..

Ultrasound-guided Brachytherapy for Cervix Cancer

S van Dyk, P Khaw, M-Y Lin, D Chang, D Bernshaw

Journal article  |  2021  |  CLINICAL ONCOLOGY

Radiotherapy and brachytherapy are the definitive treatments for locally advanced cervix cancer. The use of soft-tissue imaging, p..

Axillary dissection in sentinel lymph node positive breast cancer: Is the staging information worthwhile for patients?

David W Chang, Mathias Bressel, Carmen Hansen, Prunella Blinman, Penelope Schofield, Boon H Chua

Journal article  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

AIMS: The Z0011 randomized trial demonstrated no significant difference in axillary recurrence rate or survival with or without ax..